CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 185 filers reported holding CYTOKINETICS INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $823,598 | +20.7% | 27,957 | +33.7% | 0.00% | – |
| Q2 2023 | $682,198 | -9.2% | 20,914 | -2.0% | 0.00% | – |
| Q1 2023 | $751,078 | -22.9% | 21,344 | +0.3% | 0.00% | -100.0% |
| Q4 2022 | $974,683 | -15.0% | 21,272 | -10.1% | 0.00% | 0.0% |
| Q3 2022 | $1,147,000 | +21.5% | 23,671 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $944,000 | +29.3% | 24,036 | +21.2% | 0.00% | – |
| Q1 2022 | $730,000 | -13.0% | 19,834 | +7.7% | 0.00% | – |
| Q4 2021 | $839,000 | +49.0% | 18,415 | +16.8% | 0.00% | – |
| Q3 2021 | $563,000 | +39.0% | 15,765 | -23.0% | 0.00% | – |
| Q2 2021 | $405,000 | -7.3% | 20,477 | +8.9% | 0.00% | – |
| Q1 2021 | $437,000 | +76.9% | 18,797 | +58.0% | 0.00% | – |
| Q4 2020 | $247,000 | -16.3% | 11,897 | -12.8% | 0.00% | – |
| Q3 2020 | $295,000 | -1.7% | 13,639 | +7.0% | 0.00% | – |
| Q2 2020 | $300,000 | +26.6% | 12,745 | -36.6% | 0.00% | – |
| Q1 2020 | $237,000 | – | 20,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |